PCVX logo

Vaxcyte, Inc. (PCVX) Free cash flow

annual FCF:

-$571.79M-$207.12M(-56.80%)
December 31, 2024

Summary

  • As of today (September 14, 2025), PCVX annual free cash flow is -$571.79 million, with the most recent change of -$207.12 million (-56.80%) on December 31, 2024.
  • During the last 3 years, PCVX annual FCF has fallen by -$443.84 million (-346.89%).
  • PCVX annual FCF is now -1673.53% below its all-time high of -$32.24 million, reached on December 31, 2018.

Performance

PCVX Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

quarterly FCF:

-$130.92M+$62.10M(+32.17%)
June 30, 2025

Summary

  • As of today (September 14, 2025), PCVX quarterly free cash flow is -$130.92 million, with the most recent change of +$62.10 million (+32.17%) on June 30, 2025.
  • Over the past year, PCVX quarterly FCF has increased by +$29.45 million (+18.37%).
  • PCVX quarterly FCF is now -1318.89% below its all-time high of -$9.23 million, reached on June 30, 2020.

Performance

PCVX quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

TTM FCF:

-$564.16M+$29.45M(+4.96%)
June 30, 2025

Summary

  • As of today (September 14, 2025), PCVX TTM free cash flow is -$564.16 million, with the most recent change of +$29.45 million (+4.96%) on June 30, 2025.
  • Over the past year, PCVX TTM FCF has increased by +$18.17 million (+3.12%).
  • PCVX TTM FCF is now -5666.17% below its all-time high of -$9.78 million, reached on March 31, 2019.

Performance

PCVX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

PCVX Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-56.8%+18.4%+3.1%
3 y3 years-346.9%-226.8%-268.0%
5 y5 years-1082.8%-1318.9%-1073.2%

PCVX Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-346.9%at low-232.4%+32.2%-268.0%+8.4%
5 y5-year-1096.6%at low-1318.9%+32.2%-1080.7%+8.4%
alltimeall time-1673.5%at low-1318.9%+32.2%-5666.2%+8.4%

PCVX Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$130.92M(-32.2%)
-$564.16M(-5.0%)
Mar 2025
-
-$193.03M(+36.5%)
-$593.62M(+3.8%)
Dec 2024
-$571.79M(+56.8%)
-$141.43M(+43.2%)
-$571.79M(-7.2%)
Sep 2024
-
-$98.79M(-38.4%)
-$616.24M(+5.8%)
Jun 2024
-
-$160.37M(-6.3%)
-$582.34M(+20.7%)
Mar 2024
-
-$171.20M(-7.9%)
-$482.56M(+32.3%)
Dec 2023
-$364.67M(+106.7%)
-$185.88M(+186.5%)
-$364.67M(+48.8%)
Sep 2023
-
-$64.89M(+7.1%)
-$245.15M(+11.6%)
Jun 2023
-
-$60.60M(+13.7%)
-$219.65M(+10.3%)
Mar 2023
-
-$53.30M(-19.7%)
-$199.12M(+12.9%)
Dec 2022
-$176.44M
-$66.36M(+68.5%)
-$176.44M(+8.5%)
Sep 2022
-
-$39.39M(-1.7%)
-$162.55M(+6.0%)
Jun 2022
-
-$40.06M(+30.8%)
-$153.29M(+6.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$30.62M(-41.6%)
-$144.12M(+12.6%)
Dec 2021
-$127.95M(+167.8%)
-$52.48M(+74.1%)
-$127.95M(+47.1%)
Sep 2021
-
-$30.13M(-2.4%)
-$86.96M(+24.4%)
Jun 2021
-
-$30.89M(+113.7%)
-$69.91M(+44.9%)
Mar 2021
-
-$14.45M(+25.8%)
-$48.25M(+1.0%)
Dec 2020
-$47.78M(-1.2%)
-$11.49M(-12.2%)
-$47.78M(-7.5%)
Sep 2020
-
-$13.08M(+41.8%)
-$51.65M(+7.4%)
Jun 2020
-
-$9.23M(-34.0%)
-$48.09M(-8.5%)
Mar 2020
-
-$13.98M(-9.0%)
-$52.54M(+8.7%)
Dec 2019
-$48.34M(+49.9%)
-$15.36M(+61.4%)
-$48.34M(+46.6%)
Sep 2019
-
-$9.52M(-30.4%)
-$32.98M(+40.6%)
Jun 2019
-
-$13.68M(+39.8%)
-$23.46M(+139.8%)
Mar 2019
-
-$9.78M
-$9.78M
Dec 2018
-$32.24M
-
-

FAQ

  • What is Vaxcyte, Inc. annual free cash flow?
  • What is the all time high annual FCF for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. annual FCF year-on-year change?
  • What is Vaxcyte, Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. quarterly FCF year-on-year change?
  • What is Vaxcyte, Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. TTM FCF year-on-year change?

What is Vaxcyte, Inc. annual free cash flow?

The current annual FCF of PCVX is -$571.79M

What is the all time high annual FCF for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high annual free cash flow is -$32.24M

What is Vaxcyte, Inc. annual FCF year-on-year change?

Over the past year, PCVX annual free cash flow has changed by -$207.12M (-56.80%)

What is Vaxcyte, Inc. quarterly free cash flow?

The current quarterly FCF of PCVX is -$130.92M

What is the all time high quarterly FCF for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high quarterly free cash flow is -$9.23M

What is Vaxcyte, Inc. quarterly FCF year-on-year change?

Over the past year, PCVX quarterly free cash flow has changed by +$29.45M (+18.37%)

What is Vaxcyte, Inc. TTM free cash flow?

The current TTM FCF of PCVX is -$564.16M

What is the all time high TTM FCF for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high TTM free cash flow is -$9.78M

What is Vaxcyte, Inc. TTM FCF year-on-year change?

Over the past year, PCVX TTM free cash flow has changed by +$18.17M (+3.12%)
On this page